Turning back the Tuberculosis tide

Scientist

Volumn 19, Issue 10, 2005, Pages 22-23

  Russo, Eugene ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT; PHENOTHIAZINE; R 207910; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL RESEARCH; DRUG INDUSTRY; HEALTH CARE SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PREVALENCE; SCHIZOPHRENIA; TUBERCULOSIS;

HUMAN IMMUNODEFICIENCY VIRUS; MYCOBACTERIUM TUBERCULOSIS;

EID: 20444409102     PISSN: 08903670     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. "Global tuberculosis control - surveillance, planning, financing," WHO Report 2005, Geneva, www.who.int/tb/publications/ global_report/2005/en
2. Medicins Sans Frontieres, Running out oj breath? TB care in the 21st century, L. Hakoköngäs, ed., available online at www.msf.org/source/ annual/tbday/2004/TBDay2004report.doc
3. C. Dye et al., "Erasing the world's slow stain: Strategies to beat multidrug-resistant tuberculosis," Science, 295:2042-6, 2002.
4. J.D. McKinney et al., "Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase," Nature, 406:735-8, 2000.
5. Sassetti et al., "Genes required for mycobacterial growth defined by high density mutagenesis," Mol Microbiol, 48:77-84, 2003.
6. K. Andries et al., "A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis," Science, 307:223-7, Jan. 14, 2005.
7. E.A. Weinstein et al., "Inhibitors of type II NADH: menaquinone oxidoreductase represent a class of antitubercular drugs," Proc Natl Acad Sci, 102:4548-53, March 22, 2005.